Kirsten Gruis


Kirsten Gruis, M.D., M.S. joined Edgewise Therapeutics March 2020 as our Chief Medical Officer. Dr. Gruis is a board-certified Neuromuscular neurologist with recent experience as the Global head of the Neuromuscular franchise leading the development of SMA (spinal muscular atrophy) and DMD (Duchenne muscular dystrophy) therapeutics at Roche. Pri...

Roles at Edgewise Therapeutics

  • CMO

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.